RAPT Therapeutics Inc. (RAPT)
NASDAQ: RAPT
· Real-Time Price · USD
11.79
0.54 (4.80%)
At close: Aug 15, 2025, 3:59 PM
11.65
-1.18%
After-hours: Aug 15, 2025, 06:13 PM EDT
RAPT Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 5.29M | 5.29M | 5.29M | 5.29M | 641K | 641K | 1.53M | 2.17M | 2.28M | 3.25M | 3.23M | 3.81M | 4.36M | 4.92M | 5.33M |
Cost of Revenue | 200K | 305K | 619K | 942K | 1.85M | 2.4M | 2.97M | 3.37M | 3.19M | 3.04M | 2.85M | 2.35M | 1.62M | 920K | 231K | n/a | n/a | n/a |
Gross Profit | -200K | -305K | -619K | 4.35M | 3.44M | 2.89M | 2.32M | -2.73M | -2.55M | -1.51M | -679K | -65K | 1.63M | 2.31M | 3.58M | 4.36M | 4.92M | 5.33M |
Operating Income | -113.05M | -122.85M | -136.1M | -114.85M | -128.98M | -128.02M | -127.06M | -118.28M | -106.03M | -96.58M | -85.8M | -79.4M | -76.25M | -73.42M | -69.21M | -64.26M | -60.31M | -56.74M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -106.49M | -116.51M | -129.87M | -107.49M | -120.43M | -118.05M | -116.8M | -108.87M | -98.74M | -92.64M | -83.84M | -78.82M | -76.23M | -73.16M | -69.2M | -63.81M | -59.5M | -55.51M |
Net Income | -106.49M | -116.51M | -129.87M | -107.49M | -120.43M | -118.05M | -114.51M | -105.1M | -94.52M | -88.7M | -81.88M | -78.34M | -76.2M | -72.85M | -69.2M | -64.01M | -59.99M | -56.27M |
Selling & General & Admin | 28.68M | 28.37M | 28.57M | 26.69M | 27.14M | 27.17M | 25.74M | 24.58M | 22.77M | 21.48M | 20.24M | 19.75M | 18.45M | 16.77M | 16.04M | 15.03M | 14.45M | 13.49M |
Research & Development | 84.18M | 94.48M | 107.22M | 87.53M | 101.21M | 100.21M | 101M | 93.69M | 83.27M | 75.99M | 67.08M | 61.93M | 61.05M | 59.88M | 56.98M | 53.59M | 50.78M | 48.57M |
Other Expenses | n/a | n/a | n/a | n/a | 2.55M | 5.63M | 7.92M | 9.4M | 7.3M | 3.94M | 1.96M | 582K | 21K | 267K | 5K | -100K | 18K | 47K |
Operating Expenses | 112.85M | 122.85M | 135.79M | 114.22M | 128.35M | 127.38M | 126.74M | 118.28M | 106.03M | 97.47M | 87.32M | 81.68M | 79.5M | 76.66M | 73.02M | 68.62M | 65.23M | 62.07M |
Interest Expense | n/a | n/a | n/a | 2.29M | 2.29M | 2.29M | 2.29M | n/a | n/a | 275K | 275K | 275K | 275K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -314K | -637K | -637K | -637K | -323K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 113.99M | 123.78M | 137.03M | 114.85M | 128.98M | 128.02M | 127.06M | 118.28M | 106.03M | 97.47M | 87.32M | 81.68M | 79.5M | 76.66M | 73.02M | 68.62M | 65.23M | 62.07M |
Income Tax Expense | n/a | n/a | 270.72K | 270.72K | 270.72K | 270.72K | -2.29M | -3.77M | -4.21M | -3.94M | -1.96M | -477K | -5K | -224K | 85K | 284K | 542K | 753K |
Shares Outstanding (Basic) | 26.95M | 215.41M | 46.69M | 38.9M | 38.87M | 38.63M | 38.38M | 38.36M | 38.33M | 38.28M | 35.69M | 33.68M | 31.14M | 29.57M | 29.41M | 29.49M | 25.57M | 24.84M |
Shares Outstanding (Diluted) | 26.95M | 215.41M | 46.69M | 38.9M | 38.87M | 38.63M | 38.38M | 38.36M | 38.33M | 38.28M | 35.69M | 33.68M | 31.14M | 29.57M | 29.54M | 29.49M | 25.59M | 24.84M |
EPS (Basic) | -2.34 | -2.4 | -3.11 | -2.77 | -3.12 | -3.07 | -2.98 | -2.78 | -2.58 | -2.54 | -2.52 | -2.53 | -2.54 | -2.55 | -2.53 | -2.44 | -2.41 | -2.29 |
EPS (Diluted) | -2.34 | -2.4 | -3.11 | -2.77 | -3.12 | -3.07 | -2.98 | -2.78 | -2.58 | -2.54 | -2.52 | -2.53 | -2.54 | -2.55 | -2.53 | -2.44 | -2.41 | -2.29 |
EBITDA | -110.13M | -121.71M | -134.9M | -113.61M | -127.72M | -126.79M | -125.85M | -117.17M | -105M | -95.54M | -84.79M | -78.37M | -75.26M | -72.45M | -68.21M | -63.23M | -59.24M | -55.53M |
EBIT | -111.16M | -122.85M | -136.1M | -114.85M | -128.98M | -128.02M | -127.06M | -118.28M | -106.03M | -96.58M | -85.8M | -79.4M | -76.25M | -73.42M | -69.21M | -64.26M | -60.31M | -56.74M |
Depreciation & Amortization | 1.04M | 1.14M | 1.2M | 1.24M | 1.85M | 2.4M | 2.97M | 3.37M | 3.19M | 3.04M | 2.85M | 2.35M | 1.82M | 1.32M | 911K | 945K | 1.01M | 1.2M |